Invitation: The Quintessence of Italian Style

News on euractiv.com
JobSite
Press Releases
Services

EURACTIV's Agenda

of all European Affairs Events, conferences, presentations and workshops.

List View
Calendar view
Agenda Planner
EurActiv Events

Climate & Environment
Innovation & Enterprise
Health & Consumers
Energy

Euro & Finance
Social Europe & Jobs
Infosociety
EU Treaty & Institutions

Twitter
Facebook
RSS

form.antibot { display: none !important; } You must have JavaScript enabled to use this form.

Search form

Post an event here

Advertise on the Agenda

Invitation: The Quintessence of Italian Style

Halldis

Remind me Printer-friendly version

Date

20 Jun 2013 14:30

Address

14b, rue de la Science

Brussels

Belgium

Event Type

M - Seminar, presentation

Organiser type

Federations / Associations

Section

Innovation & Enterprise

Event Location

Brussels

Event Description

Learn about Halldis' exclusive services while sipping a glass of wine produced by one of Italyâ€™s most refined families, Ferragamo: from villas in Tuscany to event venues and serviced accommodation in Brussels.

Halldis introduction
& wine tasting
Thursday 20th June 4:30 to 7:30 pm
Science 14 Atrium
14b, rue de la Science - Brussels

RSVP by the 15th of June

This will be an opportunity
to explore our full range of services.

Looking forward to welcoming you!
Pietro Martani
Founder
Halldis

Related Events

25 Oct 2012

Financing PPP schemes - Choices, challenges and opportunities

10 Oct 2012

EuroCommerce SME Day

SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.

08 Oct 2012 to 09 Oct 2012

European Innovation Summit

COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.

06 Sep 2012

4th European Innovation Summit

Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.

05 Sep 2012

Financing and biopiracy: The challenges of the next UN Biodiversity Summit (COP11, India)

Biodiversity represents our most valuable natural heritage and its conservation is one of our most urgent challenges. Beyond its immaterial value, biodiversity plays a vital role for human beings.

04 Jul 2012 to 05 Jul 2012

Delivering better SME and Enterprise support through EU Programmes and Policies

20 Jun 2012 to 21 Jun 2012

FP7 Project Management and Audits - Practical workshop to help ensure successful implementation of your FP7 projects and survive EC audits

FP7 - Project Management and Audits in Brussels

21-22 June 2012

The FP7 - Project Management and Audits course will help ensure successful implementation of your FP7 projects and survive EC audits.

12 Jun 2012

EVIA General Assembly 2012

Annual General Meeting -12 June from 11.00 to 13.00 followed by a lunch

“The Importance of Indoor Air Quality - An Area for Future Regulation”

07 Jun 2012

EU's Research and Innovation ecosystem: what's in it for SMEs?

REGISTER NOW FOR THE EVENT

29 May 2012 to 30 May 2012

Meeting of Competitiveness Council (COMPET)

The EU ministers responsible for the single market, industry and research usually meet four times annually in the Competitiveness Council. The council is responsible for further developing the EU’s single market and ensuring the framework conditions for European industry and research.

14 May 2012

Horizon 2020: How can European research and innovation effectively respond to societal challenges?

25 Apr 2012

European Business Summit

2012 Theme: 'Skills for Growth'

13 Apr 2012

Discussion Forum ¨Market Size and Innovation in the Pharmaceutical Industry"

An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.